The global medical biomimetics market size was valued at $35.4 billion in 2021 and is projected to reach $68.9 billion by 2031, growing at a CAGR of 7.2% from 2022 to 2031. Biomimetics is a cutting-edge design idea that uses aspects and processes found in nature to solve challenging human problems. The term “biomimetics” consists of the two ancient Greek words i.e., “bios” and “mimesis,” which translate to “life” and “imitate,” respectively. Medical biomimetics is a device that draws inspiration from nature to solve complex human problems related to health. Biomimetics is used for wound healing, tissue engineering, and drug delivery. Biomimetic materials can be used to treat and preserve the tooth, cardiac regeneration, enhance natural abilities & restore the function of limbs.
Major factors driving the growth of the medical biomimetics market include a rise in technological advancement in drug delivery, such as the use of nanocapsules/nanospheres, nanocrystals, liposomes, nano lipid carriers/solid lipid nanoparticles, nanosponges and dendrimers based on biomimetics for targeted delivery of the drug. For instance, according to the review article “Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system” published in November 2022, the biological roles of cell membrane surface proteins endow nanoparticles with several functions, such as immune escape, long circulation time, and targeted delivery; therefore, these proteins are being extensively used in the fields of drug delivery. According to the same source, in the biomimetic approach, the erythrocytes membrane is used to coat polymeric nanoparticles in order to reduce macrophage uptake and systemic clearance.
Furthermore, the surge in the prevalence of cardiac diseases propels the demand for bioengineering technology to grow human replacement tissues as next-generation implants such as LifeMatrix tissues drive the growth of the medical biomimetics market. For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, about 697,000 people in the U.S. died from heart disease in 2020. According to the same source, every year, about 805,000 people in the U.S. have a heart attack. Out of these 805,000 people, 605,000 people have a first heart attack and 200,000 happen to people who have already had a heart attack.
In addition, the rise in the trend of biomimetics products, an increase in awareness regarding biomimetics product, an increase in the number of clinical trials of biomimetics product, rise in the discovery & development of effective medical biomimetics product, drives the growth of the medical biomimetics market. For instance, in July 2020, CorNeat KPro, the first synthetic cornea that bio-integrated with the eye wall, received approval to begin a clinical trial at Beilinson Hospital, Israel. The CorNeat KPro implant is designed to replace deformed, scarred, or opacified corneas and is expected to fully rehabilitate the vision of corneally blind patients immediately following implantation. The device's lens, which provides optical quality equivalent to a perfect cornea, integrates with resident ocular tissue using a unique and patented synthetic non-degradable nano-fabric skirt placed under the conjunctiva.
However, the high costs of medical biomimetics, health risks, and complications associated with medical biomimetics are expected to hamper the medical biomimetics market growth. On the contrary, unmet medical demands in developing countries and lucrative opportunities in emerging economies are expected to create immense opportunities for medical biomimetics product manufacturers in the future.
Furthermore, the healthcare business is projected to witness growth, owing to a rise in the technological advancements in orthopedic products, a rise in research in the bioengineering field, and the development of advanced medical biomimetics boosting the growth of the medical biomimetics market.
The medical biomimetics market is segmented on the basis of disease type, application, and region. On the basis of disease type, the market is classified into cardiovascular, orthopedic, ophthalmology, dental, and others. On the basis of application, the market is classified into wound healing, tissue engineering, drug delivery, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major players profiled in the report are AVINENT Science and Technology, BioHorizons, Blatchford Limited, CorNeat Vision, Curasan, Inc., Keystone Dental Group, Osteopore International Pte Ltd, Otsuka Medical Devices group (Veryan Medical Limited), Swedish Biomimetics 3000 ApS, and Zimmer Biomet.
Market research is offered along with information related to key drivers, restraints, and opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes an analysis of the regional as well as global medical biomimetics market trends, key players, market segments, application areas, and market growth Strategies.
Major factors driving the growth of the medical biomimetics market include a rise in technological advancement in drug delivery, such as the use of nanocapsules/nanospheres, nanocrystals, liposomes, nano lipid carriers/solid lipid nanoparticles, nanosponges and dendrimers based on biomimetics for targeted delivery of the drug. For instance, according to the review article “Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system” published in November 2022, the biological roles of cell membrane surface proteins endow nanoparticles with several functions, such as immune escape, long circulation time, and targeted delivery; therefore, these proteins are being extensively used in the fields of drug delivery. According to the same source, in the biomimetic approach, the erythrocytes membrane is used to coat polymeric nanoparticles in order to reduce macrophage uptake and systemic clearance.
Furthermore, the surge in the prevalence of cardiac diseases propels the demand for bioengineering technology to grow human replacement tissues as next-generation implants such as LifeMatrix tissues drive the growth of the medical biomimetics market. For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, about 697,000 people in the U.S. died from heart disease in 2020. According to the same source, every year, about 805,000 people in the U.S. have a heart attack. Out of these 805,000 people, 605,000 people have a first heart attack and 200,000 happen to people who have already had a heart attack.
In addition, the rise in the trend of biomimetics products, an increase in awareness regarding biomimetics product, an increase in the number of clinical trials of biomimetics product, rise in the discovery & development of effective medical biomimetics product, drives the growth of the medical biomimetics market. For instance, in July 2020, CorNeat KPro, the first synthetic cornea that bio-integrated with the eye wall, received approval to begin a clinical trial at Beilinson Hospital, Israel. The CorNeat KPro implant is designed to replace deformed, scarred, or opacified corneas and is expected to fully rehabilitate the vision of corneally blind patients immediately following implantation. The device's lens, which provides optical quality equivalent to a perfect cornea, integrates with resident ocular tissue using a unique and patented synthetic non-degradable nano-fabric skirt placed under the conjunctiva.
However, the high costs of medical biomimetics, health risks, and complications associated with medical biomimetics are expected to hamper the medical biomimetics market growth. On the contrary, unmet medical demands in developing countries and lucrative opportunities in emerging economies are expected to create immense opportunities for medical biomimetics product manufacturers in the future.
Furthermore, the healthcare business is projected to witness growth, owing to a rise in the technological advancements in orthopedic products, a rise in research in the bioengineering field, and the development of advanced medical biomimetics boosting the growth of the medical biomimetics market.
The medical biomimetics market is segmented on the basis of disease type, application, and region. On the basis of disease type, the market is classified into cardiovascular, orthopedic, ophthalmology, dental, and others. On the basis of application, the market is classified into wound healing, tissue engineering, drug delivery, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major players profiled in the report are AVINENT Science and Technology, BioHorizons, Blatchford Limited, CorNeat Vision, Curasan, Inc., Keystone Dental Group, Osteopore International Pte Ltd, Otsuka Medical Devices group (Veryan Medical Limited), Swedish Biomimetics 3000 ApS, and Zimmer Biomet.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical biomimetics market analysis from 2021 to 2031 to identify the prevailing medical biomimetics market opportunities.Market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes an analysis of the regional as well as global medical biomimetics market trends, key players, market segments, application areas, and market growth Strategies.
Key Market Segments
By Disease Type
- Ophthalmology
- Cardiovascular
- Orthopedic
- Dental
By Application
- Wound Healing
- Tissue Engineering
- Drug Delivery
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- AVINENT Science and Technology
- CorNeat Vision
- Osteopore International Pte Ltd
- Curasan, inc.
- Biohorizons
- Otsuka Medical Devices Co., Ltd.
- Swedish Biomimetics 3000 ApS
- Keystone Dental Group
- Blatchford Limited
- Zimmer Biomet Holding Inc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. High bargaining power of buyers
3.3.3. Low threat of substitutes
3.3.4. Low threat of new entrants
3.3.5. Moderate intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence and incidence of chronic wounds
3.4.1.2. Rise in prevalence of dental disease
3.4.1.3. Rise in prevalence of heart disease
3.4.2. Restraints
3.4.2.1. Strict regulatory rules and high per-unit cost of production
3.4.3. Opportunities
3.4.3.1. Increase in R&D and product launch
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Cardiovascular
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Orthopedic
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Ophthalmology
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Dental
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Others
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: MEDICAL BIOMIMETICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Wound Healing
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Tissue Engineering
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Drug Delivery
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: MEDICAL BIOMIMETICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Disease Type
6.2.3. Market size and forecast, by Application
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Disease Type
6.2.4.1.3. Market size and forecast, by Application
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Disease Type
6.2.4.2.3. Market size and forecast, by Application
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Disease Type
6.2.4.3.3. Market size and forecast, by Application
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Disease Type
6.3.3. Market size and forecast, by Application
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Disease Type
6.3.4.1.3. Market size and forecast, by Application
6.3.4.2. France
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Disease Type
6.3.4.2.3. Market size and forecast, by Application
6.3.4.3. UK
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Disease Type
6.3.4.3.3. Market size and forecast, by Application
6.3.4.4. Italy
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Disease Type
6.3.4.4.3. Market size and forecast, by Application
6.3.4.5. Spain
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Disease Type
6.3.4.5.3. Market size and forecast, by Application
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Disease Type
6.3.4.6.3. Market size and forecast, by Application
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Disease Type
6.4.3. Market size and forecast, by Application
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Disease Type
6.4.4.1.3. Market size and forecast, by Application
6.4.4.2. Japan
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Disease Type
6.4.4.2.3. Market size and forecast, by Application
6.4.4.3. India
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Disease Type
6.4.4.3.3. Market size and forecast, by Application
6.4.4.4. Australia
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Disease Type
6.4.4.4.3. Market size and forecast, by Application
6.4.4.5. Rest of Asia-Pacific
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Disease Type
6.4.4.5.3. Market size and forecast, by Application
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Disease Type
6.5.3. Market size and forecast, by Application
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Disease Type
6.5.4.1.3. Market size and forecast, by Application
6.5.4.2. Saudi Arabia
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Disease Type
6.5.4.2.3. Market size and forecast, by Application
6.5.4.3. South Africa
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Disease Type
6.5.4.3.3. Market size and forecast, by Application
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Disease Type
6.5.4.4.3. Market size and forecast, by Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1. Otsuka Medical Devices Co., Ltd.
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. AVINENT Science and Technology
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.3. CorNeat Vision
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Key strategic moves and developments
8.4. Swedish Biomimetics 3000 ApS
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.5. Osteopore International Pte Ltd
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Curasan, inc.
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.7. Keystone Dental Group
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Key strategic moves and developments
8.8. Zimmer Biomet Holding Inc.
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.9. Biohorizons
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.10. Blatchford Limited
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Key strategic moves and developments
List of Tables
Table 01. Global Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 02. Medical Biomimetics Market for Cardiovascular, by Region, 2021-2031 (Revenue, $Million)
Table 03. Medical Biomimetics Market for Orthopedic, by Region, 2021-2031 (Revenue, $Million)
Table 04. Medical Biomimetics Market for Ophthalmology, by Region, 2021-2031 (Revenue, $Million)
Table 05. Medical Biomimetics Market for Dental, by Region, 2021-2031 (Revenue, $Million)
Table 06. Medical Biomimetics Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 07. Global Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 08. Medical Biomimetics Market for Wound Healing, by Region, 2021-2031 (Revenue, $Million)
Table 09. Medical Biomimetics Market for Tissue Engineering, by Region, 2021-2031 (Revenue, $Million)
Table 10. Medical Biomimetics Market for Drug Delivery, by Region, 2021-2031 (Revenue, $Million)
Table 11. Medical Biomimetics Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 12. Medical Biomimetics Market, by Region, 2021-2031 (Revenue, $Million)
Table 13. North America Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 14. North America Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 15. North America Medical Biomimetics Market, by Country, 2021-2031 (Revenue, $Million)
Table 16. U.S. Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 17. U.S. Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 18. Canada Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 19. Canada Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 20. Mexico Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 21. Mexico Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 22. Europe Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 23. Europe Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 24. Europe Medical Biomimetics Market, by Country, 2021-2031 (Revenue, $Million)
Table 25. Germany Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 26. Germany Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 27. France Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 28. France Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 29. UK Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 30. UK Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 31. Italy Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 32. Italy Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 33. Spain Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 34. Spain Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 35. Rest of Europe Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 36. Rest of Europe Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 37. Asia-Pacific Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 38. Asia-Pacific Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 39. Asia-Pacific Medical Biomimetics Market, by Country, 2021-2031 (Revenue, $Million)
Table 40. China Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 41. China Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 42. Japan Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 43. Japan Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 44. India Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 45. India Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 46. Australia Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 47. Australia Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 48. Rest of Asia-Pacific Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 49. Rest of Asia-Pacific Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 50. LAMEA Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 51. LAMEA Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 52. LAMEA Medical Biomimetics Market, by Country, 2021-2031 (Revenue, $Million)
Table 53. Brazil Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 54. Brazil Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 55. Saudi Arabia Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 56. Saudi Arabia Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 57. South Africa Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 58. South Africa Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 59. Rest of LAMEA Medical Biomimetics Market, by Disease Type, 2021-2031 (Revenue, $Million)
Table 60. Rest of LAMEA Medical Biomimetics Market, by Application, 2021-2031 (Revenue, $Million)
Table 61. Otsuka Medical Devices Co. Ltd.: Key Executives
Table 62. Otsuka Medical Devices Co. Ltd.: Company Snapshot
Table 63. Otsuka Medical Devices Co. Ltd.: Product Segments
Table 64. Otsuka Medical Devices Co. Ltd.: Product Portfolio
Table 65. Otsuka Medical Devices Co. Ltd.: Key Strategies
Table 66. Avinent Science and Technology: Key Executives
Table 67. Avinent Science and Technology: Company Snapshot
Table 68. Avinent Science and Technology: Product Segments
Table 69. Avinent Science and Technology: Product Portfolio
Table 70. Corneat Vision: Key Executives
Table 71. Corneat Vision: Company Snapshot
Table 72. Corneat Vision: Product Segments
Table 73. Corneat Vision: Product Portfolio
Table 74. Corneat Vision: Key Strategies
Table 75. Swedish Biomimetics 3000 Aps: Key Executives
Table 76. Swedish Biomimetics 3000 Aps: Company Snapshot
Table 77. Swedish Biomimetics 3000 Aps: Product Segments
Table 78. Swedish Biomimetics 3000 Aps: Product Portfolio
Table 79. Osteopore International Pte Ltd.: Key Executives
Table 80. Osteopore International Pte Ltd.: Company Snapshot
Table 81. Osteopore International Pte Ltd.: Product Segments
Table 82. Osteopore International Pte Ltd.: Product Portfolio
Table 83. Osteopore International Pte Ltd.: Key Strategies
Table 84. Curasan, Inc.: Key Executives
Table 85. Curasan, Inc.: Company Snapshot
Table 86. Curasan, Inc.: Product Segments
Table 87. Curasan, Inc.: Product Portfolio
Table 88. Keystone Dental Group: Key Executives
Table 89. Keystone Dental Group: Company Snapshot
Table 90. Keystone Dental Group: Product Segments
Table 91. Keystone Dental Group: Product Portfolio
Table 92. Keystone Dental Group: Key Strategies
Table 93. Zimmer Biomet Holding Inc.: Key Executives
Table 94. Zimmer Biomet Holding Inc.: Company Snapshot
Table 95. Zimmer Biomet Holding Inc.: Product Segments
Table 96. Zimmer Biomet Holding Inc.: Product Portfolio
Table 97. Biohorizons: Key Executives
Table 98. Biohorizons: Company Snapshot
Table 99. Biohorizons: Product Segments
Table 100. Biohorizons: Product Portfolio
Table 101. Blatchford Limited: Key Executives
Table 102. Blatchford Limited: Company Snapshot
Table 103. Blatchford Limited: Product Segments
Table 104. Blatchford Limited: Product Portfolio
Table 105. Blatchford Limited: Key Strategies
List of Figures
Figure 01. Medical Biomimetics Market, 2021-2031
Figure 02. Segmentation of Medical Biomimetics Market, 2021-2031
Figure 03. Top Investment Pockets in Medical Biomimetics Market (2022-2031)
Figure 04. Low Bargaining Power of Suppliers
Figure 05. High Bargaining Power of Buyers
Figure 06. Low Threat of Substitutes
Figure 07. Low Threat of New Entrants
Figure 08. Moderate Intensity of Rivalry
Figure 09. Drivers, Restraints and Opportunities: Globalmedical Biomimetics Market
Figure 10. Medical Biomimetics Market, by Disease Type, 2021(%)
Figure 11. Comparative Share Analysis of Medical Biomimetics Market for Cardiovascular, by Country 2021-2031(%)
Figure 12. Comparative Share Analysis of Medical Biomimetics Market for Orthopedic, by Country 2021-2031(%)
Figure 13. Comparative Share Analysis of Medical Biomimetics Market for Ophthalmology, by Country 2021-2031(%)
Figure 14. Comparative Share Analysis of Medical Biomimetics Market for Dental, by Country 2021-2031(%)
Figure 15. Comparative Share Analysis of Medical Biomimetics Market for Others, by Country 2021-2031(%)
Figure 16. Medical Biomimetics Market, by Application, 2021(%)
Figure 17. Comparative Share Analysis of Medical Biomimetics Market for Wound Healing, by Country 2021-2031(%)
Figure 18. Comparative Share Analysis of Medical Biomimetics Market for Tissue Engineering, by Country 2021-2031(%)
Figure 19. Comparative Share Analysis of Medical Biomimetics Market for Drug Delivery, by Country 2021-2031(%)
Figure 20. Comparative Share Analysis of Medical Biomimetics Market for Others, by Country 2021-2031(%)
Figure 21. Medical Biomimetics Market by Region, 2021
Figure 22. U.S. Medical Biomimetics Market, 2021-2031 ($Million)
Figure 23. Canada Medical Biomimetics Market, 2021-2031 ($Million)
Figure 24. Mexico Medical Biomimetics Market, 2021-2031 ($Million)
Figure 25. Germany Medical Biomimetics Market, 2021-2031 ($Million)
Figure 26. France Medical Biomimetics Market, 2021-2031 ($Million)
Figure 27. UK Medical Biomimetics Market, 2021-2031 ($Million)
Figure 28. Italy Medical Biomimetics Market, 2021-2031 ($Million)
Figure 29. Spain Medical Biomimetics Market, 2021-2031 ($Million)
Figure 30. Rest of Europe Medical Biomimetics Market, 2021-2031 ($Million)
Figure 31. China Medical Biomimetics Market, 2021-2031 ($Million)
Figure 32. Japan Medical Biomimetics Market, 2021-2031 ($Million)
Figure 33. India Medical Biomimetics Market, 2021-2031 ($Million)
Figure 34. Australia Medical Biomimetics Market, 2021-2031 ($Million)
Figure 35. Rest of Asia-Pacific Medical Biomimetics Market, 2021-2031 ($Million)
Figure 36. Brazil Medical Biomimetics Market, 2021-2031 ($Million)
Figure 37. Saudi Arabia Medical Biomimetics Market, 2021-2031 ($Million)
Figure 38. South Africa Medical Biomimetics Market, 2021-2031 ($Million)
Figure 39. Rest of LAMEA Medical Biomimetics Market, 2021-2031 ($Million)
Figure 40. Top Winning Strategies, by Year
Figure 41. Top Winning Strategies, by Development
Figure 42. Top Winning Strategies, by Company
Figure 43. Product Mapping of Top 10 Players
Figure 44. Competitive Dashboard
Figure 45. Competitive Heatmap: Medical Biomimetics Market
Figure 46. Top Player Positioning, 2021
Figure 47. Otsuka Medical Devices Co. Ltd.: Net Revenue, 2019-2021 ($Billion)
Figure 48. Otsuka Medical Devices Co. Ltd.: Research & Development Expenditure, 2019-2021 ($Billion)
Figure 49. Otsuka Medical Devices Co. Ltd.: Revenue Share by Segment, 2021 (%)
Figure 50. Osteopore International Pte Ltd.: Net Revenue, 2019-2021 ($Million)
Figure 51. Osteopore International Pte Ltd.: Revenue Share by Region, 2021 (%)
Figure 52. Zimmer Biomet Holding Inc.: Net Sales, 2019-2021 ($Million)
Figure 53. Zimmer Biomet Holding Inc.: Revenue Share by Region, 2021 (%)
Figure 54. Zimmer Biomet Holding Inc.: Revenue Share by Segment, 2021 (%)
Executive Summary
According to the report titled, 'Medical Biomimetics Market,' the medical biomimetics market was valued at $35.4 billion in 2021 and is estimated to reach $68.9 billion by 2031, growing at a CAGR of 7.2% from 2022 to 2031.Medical biomimetics refers to the application of principles and designs from biology to the development of medical products and technologies. The goal of medical biomimetics is to create medical products and technologies that are more effective, efficient, and minimally invasive, and that work in harmony with the body's natural systems. Medical biomimetics draws inspiration from a wide range of biological systems and structures, such as the structure of bones, the way that joints move, and the ways that cells and tissues interact. This knowledge is then used to design medical products and technologies that mimic the function of these biological systems.
Key factors driving the growth of the medical biomimetics market include the increasing prevalence of chronic diseases such as cardiovascular and orthopedic diseases, the aging population, advancements in materials science, and technological innovations in fields such as 3D printing and robotics. For instance, according to the Centers for Disease Control and Prevention 2021, 58.5 million adults have been diagnosed with arthritis in the U.S. and this number is expected to rise to 78 million by 2040. Moreover, the rise in advancement in novel drug delivery systems such as the use of solid lipid nanoparticles, nanosponges, and dendrimers based on biomimetics for targeted delivery of drugs, and the increase in the number of clinical trials of biomimetics products drives the growth of medical biomimetics market. Dental biomimetic is used in dental bone grafts and is used to replace a missing tooth, and to rebuild the jaw before getting dentures. Therefore, the increase in the availability of advanced dental biomimetic products drives the growth of the market. For instance, Keystone Dental Group offers bone substitutes including OCS-B OsteoConductive Substitute-Bovine, MBCP Synthetic Resorbable Bone Graft; membranes including Cytoplast TXT-200 Non-Resorbable. Hence, such all factors drive the growth of the medical biomimetics market.
In addition, the growing demand for better healthcare and increasing healthcare expenditure is driving the growth of the medical biomimetics market drives the growth of medical biomimetics market. Furthermore, the rise in the incidence of trauma and accidents further cause wounds and increase the demand for the biomimetic product for wound healing. For instance, according to the review article Chronic wounds” published in July 2022, it is estimated that 1-2% of the population worldwide experience a chronic wound in their lifetime.
The factors that offer growth opportunities to the key players in the market include a rise in chronic diseases such as cardiovascular disease, diabetes, and cancer which further drive demand for advanced medical technologies that can help diagnose, treat, and manage these conditions. As a result, the key players engaged in the medical devices industry have invested in R&D for the discovery of new biomimetics products that are expected to gain high traction and provide lucrative opportunities for the growth of the medical biomimetics market.
The medical biomimetics market is segmented on the basis of disease type, application, and region. On the basis of disease type, the market is classified into cardiovascular, orthopedic, ophthalmology, dental, and others. On the basis of application, the market is classified into wound healing, tissue engineering, drug delivery, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The key players profiled in the study include AVINENT Science and Technology, BioHorizons, Blatchford Limited, CorNeat Vision, Curasan, Inc., Keystone Dental Group, Osteopore International Pte Ltd, Otsuka Medical Devices group (Veryan Medical Limited), Swedish Biomimetics 3000 ApS, and Zimmer Biomet. The players in the market have been actively engaged in the adoption of various Strategies such as acquisition to remain competitive and gain an advantage over the competitors in the market. For instance, in September 2021, Keystone Dental Inc., the largest independent dental implant company announced the acquisition of Osteon Medical, a Melbourne, Australia-based technology company providing digital solutions for clinicians and dental laboratories leveraging proprietary software and unique hardware developments, significantly improving digital workflows. This will increase Keystone's global visibility in the dental market with innovative solutions and a high-value proposition.
Key Market Insights
By product, the dental segment was the highest revenue contributor to the market in 2021 and is estimated to reach $ 25,126.6 million by 2031. The same segment is expected to be the fastest-growing segment with a CAGR of 7.6% during the forecast period.By application, the wound healing segment was the highest revenue contributor to the market in 2021. The tissue engineering segment is expected to witness the highest CAGR of 7.9%.
Based on region, the North American segment was the highest revenue contributor to the market in 2021. However, the Asia-Pacific segment is expected to be the fastest-growing segment with a CAGR of 8.5% during the forecast period.
Companies Mentioned
- AVINENT Science and Technology
- CorNeat Vision
- Osteopore International Pte Ltd
- Curasan, inc.
- Biohorizons
- Otsuka Medical Devices Co., Ltd.
- Swedish Biomimetics 3000 ApS
- Keystone Dental Group
- Blatchford Limited
- Zimmer Biomet Holding Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 221 |
| Published | January 2023 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 35.4 billion |
| Forecasted Market Value ( USD | $ 68.9 billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
